REQUEST A DEMO
Total
USD $0.00
Search more companies

Icon Clinical Research SRL (Romania)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Icon Clinical Research SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Icon Clinical Research SRL is an enterprise in Romania, with the main office in Bucharest. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was established on January 14, 2008. The total number of employees is currently 118 (2022). In its most recent financial highlights, the company reported a net sales revenue increase of 40.61% in 2023. There was a total growth of 28.96% in Icon Clinical Research SRL’s total assets over the same period. The enterprise’s net profit margin decreased by 0.37% in 2023.

Headquarters
Calea Floreasca Nr. 246C
Bucharest; Bucharest;

Contact Details: Purchase the Icon Clinical Research SRL report to view the information.

Basic Information
Total Employees:
Purchase the Icon Clinical Research SRL report to view the information.
Outstanding Shares:
Purchase the Icon Clinical Research SRL report to view the information.
Registered Capital:
Purchase the Icon Clinical Research SRL report to view the information.
Incorporation Date:
January 14, 2008
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Icon Clinical Research SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
40.61%
Total operating revenue
40.61%
Operating profit (EBIT)
40.84%
EBITDA
45.35%
Net Profit (Loss) for the Period
30.28%
Total assets
28.96%
Total equity
35.8%
Operating Profit Margin (ROS)
0.01%
Net Profit Margin
-0.37%
Return on Equity (ROE)
-1.12%
Quick Ratio
0.31%
Cash Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?